Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Price Passes Above 50-Day Moving Average of $10.77

Bavarian Nordic A/S (OTCMKTS:BVNRYGet Rating)’s stock price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $10.77 and traded as high as $12.29. Bavarian Nordic A/S shares last traded at $12.25, with a volume of 48,595 shares changing hands.

Bavarian Nordic A/S Stock Performance

The stock has a market cap of $2.60 billion, a P/E ratio of -28.49 and a beta of 1.56. The stock’s fifty day moving average is $10.77 and its 200 day moving average is $11.71.

Bavarian Nordic A/S (OTCMKTS:BVNRYGet Rating) last issued its quarterly earnings data on Wednesday, November 9th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.04). Bavarian Nordic A/S had a negative return on equity of 8.53% and a negative net margin of 25.83%. The company had revenue of $135.96 million for the quarter, compared to analysts’ expectations of $153.80 million. Equities research analysts predict that Bavarian Nordic A/S will post -0.23 EPS for the current year.

About Bavarian Nordic A/S

(Get Rating)

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer.

Featured Stories

Receive News & Ratings for Bavarian Nordic A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic A/S and related companies with's FREE daily email newsletter.